<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The PEA-15/PED (phosphoprotein enriched in astrocytes 15kD/phosphoprotein enriched in <z:mp ids='MP_0002055'>diabetes</z:mp>) protein is a multifunctional phosphoprotein involved in various signaling pathways which determine survival, proliferation, and migration of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we investigated the expression and cellular functions of PEA-15 in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>PEA-15 is expressed in the majority of human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, predominantly in well differentiated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> areas </plain></SENT>
<SENT sid="3" pm="."><plain>A tissue microarray analysis of 1262 human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> specimens from the DACHS study showed that PEA-15 expression is significantly associated with a low pT stadium as defined by limited invasion into the bowel wall </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, patients with PEA-15-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> exhibited a significantly longer <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific survival time </plain></SENT>
<SENT sid="5" pm="."><plain>To investigate the functional relevance of PEA-15 expression on a cellular level, we over-expressed PEA-15 in several <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines </plain></SENT>
<SENT sid="6" pm="."><plain>Increased expression of PEA-15 resulted in a strong inhibition of clonogenicity, proliferation, and invasiveness of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>These effects were associated with a PEA-15-dependent down-regulation of integrin αvβ5 as well as with elevated levels of the phosphorylated MAP kinase ERK1/2 </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, expression of PEA-15 resulted in significant protection from cell <z:hpo ids='HP_0011420'>death</z:hpo> induced by cytotoxic drugs (5-FU, <z:chebi fb="2" ids="27899">cisplatin</z:chebi>), by the <z:hpo ids='HP_0011420'>death</z:hpo> ligand TRAIL, or by serum withdrawal </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, the PEA-15 protein regulates invasiveness, proliferation, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> resistance in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="10" pm="."><plain>PEA-15 might play an important role in chemoresistance, progression and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>